Sökning: WFRF:(Foster Eric) > Phase 3 trial of hu...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06131naa a2200685 4500 | |
001 | oai:DiVA.org:uu-450607 | |
003 | SwePub | |
008 | 210817s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4506072 URI |
024 | 7 | a https://doi.org/10.1111/ajt.161742 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Markmann, James F.u Harvard Med Sch, Div Transplant Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA.4 aut |
245 | 1 0 | a Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes |
264 | 1 | b John Wiley & Sons,c 2021 |
338 | a print2 rdacarrier | |
520 | a Allogeneic islet transplant offers a minimally invasive option for beta cell replacement in the treatment of type 1 diabetes (T1D). The CIT consortium trial of purified human pancreatic islets (PHPI) in patients with T1D after kidney transplant (CIT06), a National Institutes of Health-sponsored phase 3, prospective, open-label, single-arm pivotal trial of PHPI, was conducted in 24 patients with impaired awareness of hypoglycemia while receiving intensive insulin therapy. PHPI were manufactured using standardized processes. PHPI transplantation was effective with 62.5% of patients achieving the primary endpoint of freedom from severe hypoglycemic events and HbA(1c) <= 6.5% or reduced by >= 1 percentage point at 1 year posttransplant. Median HbA(1c)declined from 8.1% before to 6.0% at 1 year and 6.3% at 2 and 3 years following transplant (P < .001 for all vs baseline), with related improvements in hypoglycemia awareness and glucose variability. The improved metabolic control was associated with better health-related and diabetes-related quality of life. The procedure was safe and kidney allograft function remained stable after 3 years. These results add to evidence establishing allogeneic islet transplant as a safe and effective treatment for patients with T1D and unstable glucose control despite intensive insulin treatment, supporting the indication for PHPI in the post-renal transplant setting. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
653 | a basic (laboratory) research | |
653 | a science | |
653 | a clinical research | |
653 | a practice | |
653 | a diabetes | |
653 | a type 1 | |
653 | a islet transplantation | |
700 | 1 | a Rickels, Michael R.u Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.4 aut |
700 | 1 | a Eggerman, Thomas L.u NIDDK, NIH, Bethesda, MD 20892 USA.4 aut |
700 | 1 | a Bridges, Nancy D.u NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.4 aut |
700 | 1 | a Lafontant, David E.u Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut |
700 | 1 | a Qidwai, Julieu Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut |
700 | 1 | a Foster, Ericu Ferring Pharmaceut, Parsippany, NJ USA.4 aut |
700 | 1 | a Clarke, William R.u Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut |
700 | 1 | a Kamoun, Maleku Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.4 aut |
700 | 1 | a Alejandro, Rodolfou Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.;Univ Miami, Miller Sch Med, Clin Cell Transplant Program, Miami, FL 33136 USA.4 aut |
700 | 1 | a Bellin, Melena D.u Univ Minnesota, Dept Endocrinol, Minneapolis, MN USA.4 aut |
700 | 1 | a Chaloner, Kathrynu Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut |
700 | 1 | a Czarniecki, Christine W.u NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.4 aut |
700 | 1 | a Goldstein, Julia S.u NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.4 aut |
700 | 1 | a Hering, Bernhard J.u Univ Minnesota, Schulze Diabet Inst, Minneapolis, MN USA.;Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.4 aut |
700 | 1 | a Hunsicker, Lawrence G.u Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut |
700 | 1 | a Kaufman, Dixon B.u Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI USA.4 aut |
700 | 1 | a Korsgren, Olleu Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)ollekors |
700 | 1 | a Larsen, Christian P.u Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA.4 aut |
700 | 1 | a Luo, Xunrongu Duke Univ, Dept Med, Durham, NC USA.4 aut |
700 | 1 | a Naji, Aliu Univ Penn, Perelman Sch Med, Dept Surg, Div Transplantat, Philadelphia, PA 19104 USA.4 aut |
700 | 1 | a Oberholzer, Joseu Univ Illinois, Dept Surg, Chicago, IL 60680 USA.4 aut |
700 | 1 | a Posselt, Andrew M.u Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.4 aut |
700 | 1 | a Ricordi, Camillou Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.;Univ Miami, Miller Sch Med, Clin Cell Transplant Program, Miami, FL 33136 USA.4 aut |
700 | 1 | a Senior, Peter A.u Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada.;Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada.4 aut |
700 | 1 | a Shapiro, A. M. Jamesu Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada.;Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada.4 aut |
700 | 1 | a Stock, Peter G.u Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.4 aut |
700 | 1 | a Turgeon, Nicole A.u Univ Texas Med Sch, Dept Surg, Austin, TX USA.4 aut |
710 | 2 | a Harvard Med Sch, Div Transplant Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA.b Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.4 org |
773 | 0 | t American Journal of Transplantationd : John Wiley & Sonsg 21:4, s. 1477-1492q 21:4<1477-1492x 1600-6135x 1600-6143 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-450607 |
856 | 4 8 | u https://doi.org/10.1111/ajt.16174 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.